These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 21766663)

  • 1. [Anti-hypertensive treatment in metabolic syndrome--focus on ARB or ACE inhibitor].
    Yano Y; Kario K
    Nihon Rinsho; 2011 Jan; 69 Suppl 1():576-81. PubMed ID: 21766663
    [No Abstract]   [Full Text] [Related]  

  • 2. Metabolic syndrome: treatment of hypertensive patients.
    Israili ZH; Lyoussi B; Hernández-Hernández R; Velasco M
    Am J Ther; 2007; 14(4):386-402. PubMed ID: 17667215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypertensive treatment in patients with metabolic syndrome.
    Siegel D; Swislocki AL
    Metab Syndr Relat Disord; 2010 Apr; 8(2):95-104. PubMed ID: 20156078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experience with angiotensin II antagonists in hypertensive patients.
    Waeber B; Burnier M; Nussberger J; Brunner HR
    Clin Exp Pharmacol Physiol; 1996 Sep; 23 Suppl 3():S142-6. PubMed ID: 21143288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Question: Should patients who have a significant increase in BUN or creatinine (more than 30% above baseline) in response to an ACEI or ARB be tested for renal stenosis?
    Dunlap P; Salinas RC; Welborn T
    J Okla State Med Assoc; 2010; 103(11-12):545-6. PubMed ID: 21319588
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hypertensive patient with metabolic syndrome: would you prescribe a diuretic as the initial treatment? (interview by Thomas Meissner)].
    Düsing R
    MMW Fortschr Med; 2008 Mar; 150(12):17. PubMed ID: 18533590
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of angiotensin receptor blockers in diabetic nephropathy.
    Sharma AM; Weir MR
    Postgrad Med; 2011 May; 123(3):109-21. PubMed ID: 21566421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renin Angiotensin Aldosterone System Blockade: Little to No Rationale for ACE Inhibitor and ARB Combinations.
    Holdiness A; Monahan K; Minor D; de Shazo RD
    Am J Med; 2011 Jan; 124(1):15-9. PubMed ID: 21187182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compliance, persistence, healthcare resource use, and treatment costs associated with aliskiren plus ARB versus ACE inhibitor plus ARB combination therapy: in US patients with hypertension.
    Chang J; Yang W; Kahler KH; Fellers T; Orloff J; Bensimon AG; Yu AP; Fan CP; Wu EQ
    Am J Cardiovasc Drugs; 2011; 11(1):21-32. PubMed ID: 21142294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circadian rhythms in blood pressure regulation and optimization of hypertension treatment with ACE inhibitor and ARB medications.
    Hermida RC; Ayala DE; Fernández JR; Portaluppi F; Fabbian F; Smolensky MH
    Am J Hypertens; 2011 Apr; 24(4):383-91. PubMed ID: 20930708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct time courses of renal protective action of angiotensin receptor antagonists and ACE inhibitors in chronic renal disease.
    Matsuda H; Hayashi K; Saruta T
    J Hum Hypertens; 2003 Apr; 17(4):271-6. PubMed ID: 12692572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The CARI guidelines. Inhibition of the renin-angiotensin system.
    Mount P; Kumar SK; MacGinley R; Mantha M; Roberts M; Mangos G;
    Nephrology (Carlton); 2010 Apr; 15 Suppl 1():S234-43. PubMed ID: 20591037
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of hypertension in patients associated with type 2 diabetes mellitus or metabolic syndrome].
    Katayama S
    Nihon Rinsho; 2011 Nov; 69(11):2025-9. PubMed ID: 22111325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Not just numbers, but years of science: putting the ACE inhibitor-ARB meta-analyses into context.
    Ferrari R; Rosano GM
    Int J Cardiol; 2013 Jun; 166(2):286-8. PubMed ID: 23452882
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical application of ARB and ACEI].
    Matsuoka H
    Nihon Rinsho; 2002 Oct; 60(10):1981-6. PubMed ID: 12397695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin converting enzyme inhibitor or angiotensin II receptor blocker for the prevention of type 2 diabetes mellitus?
    Chen CC; Chiang AN; Hsieh MH
    Diabetes Res Clin Pract; 2010 Nov; 90(2):e25-6. PubMed ID: 20591527
    [No Abstract]   [Full Text] [Related]  

  • 18. The role of angiotensin receptor blockers in patients with angiotensin-converting enzyme inhibitor-induced angioedema.
    Beavers CJ; Dunn SP; Macaulay TE
    Ann Pharmacother; 2011 Apr; 45(4):520-4. PubMed ID: 21427294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers and diabetes: a meta-analysis of placebo-controlled clinical trials.
    Tocci G; Paneni F; Palano F; Sciarretta S; Ferrucci A; Kurtz T; Mancia G; Volpe M
    Am J Hypertens; 2011 May; 24(5):582-90. PubMed ID: 21331058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Usefulness of ARB in heart failure].
    Tsutsui H
    Nihon Rinsho; 2009 Apr; 67(4):751-7. PubMed ID: 19348238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.